Regen-D Gel (Epidermal Growth Factor)

Product Overview

Regen-D Gel is a topical formulation designed for the management of diabetic foot ulcers. It contains epidermal growth factor, a protein that stimulates cellular proliferation and tissue repair. The gel is supplied in a 15 gram tube and is intended for external application to the affected ulcer site. The product is manufactured by Bharat Biotech International, a company known for its work in vaccine and biologic development. Regen-D Gel is positioned within the diabetes care category, addressing a chronic wound that affects millions of individuals with diabetes worldwide. Clinical studies have explored the use of growth factor‑based gels in chronic wound healing, showing potential to accelerate closure when combined with standard wound care practices.

What is Regen-D Gel?

Regen-D Gel is a topical gel that delivers epidermal growth factor directly to the wound surface. The active ingredient is a recombinant form of human epidermal growth factor, engineered to promote the migration of keratinocytes and fibroblasts, which are essential for re‑epithelialization. The gel matrix is designed to maintain moisture, protect the wound from mechanical trauma, and provide a controlled release of the growth factor over several days. Its composition includes carbomer, propylene glycol, and purified water, which together create a non‑greasy, transparent gel that adheres to the wound bed without excessive runoff.

Uses and Benefits

The primary indication for Regen-D Gel is the treatment of diabetic foot ulcers that have persisted for more than four weeks despite conventional dressing changes and off‑loading strategies. In clinical practice, the gel is used as an adjunct to standard wound care to enhance the natural healing cascade. Benefits reported in peer‑reviewed studies include a reduction in ulcer surface area, decreased pain scores, and lower rates of amputation when used early in the disease course. Because the formulation is applied once daily, it simplifies the dressing routine for patients and caregivers, which can improve adherence to therapy. Moreover, the growth factor component targets the underlying cellular deficit that often delays healing in diabetic microangiopathy.

How It Works

Epidermal growth factor (EGF) binds to the EGFR receptor on skin cells, triggering intracellular signaling pathways such as MAPK and PI3K that drive cell proliferation, migration, and survival. In diabetic wounds, the local concentration of EGF is often diminished due to chronic inflammation and impaired angiogenesis. By topping up this signaling molecule, Regen-D Gel helps to restart the cascade that leads to the formation of new tissue. The gel’s carrier system protects EGF from proteolytic degradation, ensuring that a biologically active dose reaches the wound bed for an extended period. This mechanism mirrors the physiological wound repair process, where growth factors are released in a tightly regulated temporal pattern.

Dosage Guidelines

The recommended dosage is a thin layer of Regen-D Gel applied to the cleaned ulcer once daily, preferably after a gentle debridement and before applying a secondary dressing. The amount should be sufficient to cover the wound surface without pooling. Treatment duration typically ranges from four to twelve weeks, depending on ulcer size and response to therapy. If no measurable reduction in wound area occurs after six weeks, clinicians may reassess the patient and consider alternative wound‑care strategies. Patients should wash their hands before and after application, and any excess gel should be gently removed with sterile gauze to prevent accumulation around the wound edge.

Side Effects

Most users experience mild, transient side effects that do not require medical intervention. The most common adverse reactions include localized erythema, itching, or a burning sensation at the application site. These symptoms usually resolve within 24 to 48 hours as the skin adapts to the formulation. Less frequently, patients may report dermatitis, edema, or the development of small blisters. In rare cases, hypersensitivity reactions such as rash or urticaria have been documented. If any sign of infection, increasing pain, or systemic symptoms such as fever occurs, the gel should be discontinued and a healthcare professional consulted.

Warnings and Precautions

Regen-D Gel is for external use only and should not be ingested. The product must be stored at room temperature, away from direct sunlight, and kept out of reach of children. It is not intended for use on deep puncture wounds, burns, or surgical incisions that have not been evaluated by a qualified clinician. Patients with known hypersensitivity to any component of the gel should avoid its use. Concurrent use of other topical antiseptics or antibiotics should be coordinated with the treating physician to avoid potential interactions. Individuals who are pregnant or breastfeeding should consult a healthcare provider before initiating therapy, as safety data in these populations remain limited.

FAQs

Q1: What is the active ingredient in Regen-D Gel?

The active ingredient is recombinant human epidermal growth factor, a laboratory‑produced protein that mimics the natural growth factor involved in skin repair. Read more on Wikipedia.

Q2: How often should I apply the gel?

Regen-D Gel should be applied once daily to the cleaned ulcer surface. Consistent daily application helps maintain optimal growth factor levels for wound healing.

Q3: Can I use this gel with other wound dressings?

Yes. After cleaning the ulcer and applying a thin layer of Regen-D Gel, a secondary dressing can be placed over the area as directed by your clinician. Avoid using harsh antiseptics at the same time without medical guidance.

Q4: Is Regen-D Gel safe for all patients with diabetes?

It is not suitable for individuals with known allergy to any of the formulation components. Patients should review the ingredient list and consult their healthcare provider, especially if they are using other topical medications. U.S. Food and Drug Administration provides guidance on safe use of topical products.

Q5: Where can I find authoritative information about growth factor therapies?

Trusted sources include the National Institutes of Health, PubMed, and MedlinePlus. These sites offer evidence‑based summaries of clinical research on epidermal growth factor in wound healing.